IDR 600.0
(-0.83%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 2780.27 Billion IDR | -21.79% |
2022 | 3592.83 Billion IDR | -18.28% |
2021 | 4396.28 Billion IDR | 20.21% |
2020 | 3657.13 Billion IDR | 4.39% |
2019 | 3503.28 Billion IDR | 26.01% |
2018 | 2780.17 Billion IDR | 26.26% |
2017 | 2201.87 Billion IDR | 18.13% |
2016 | 1863.89 Billion IDR | 21.29% |
2015 | 1536.75 Billion IDR | 10.92% |
2014 | 1385.48 Billion IDR | 7.22% |
2013 | 1292.15 Billion IDR | 9.95% |
2012 | 1175.16 Billion IDR | 13.21% |
2011 | 1038.01 Billion IDR | 14.76% |
2010 | 904.51 Billion IDR | 14.75% |
2009 | 788.25 Billion IDR | 9.14% |
2008 | 722.24 Billion IDR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 820.83 Billion IDR | 198.84% |
2024 Q3 | 658.34 Billion IDR | -13.24% |
2024 Q2 | 758.84 Billion IDR | -7.55% |
2023 Q4 | 274.67 Billion IDR | -72.23% |
2023 Q1 | 858.58 Billion IDR | -19.64% |
2023 FY | 2809.86 Billion IDR | -21.79% |
2023 Q2 | 970.11 Billion IDR | 12.99% |
2023 Q3 | 989.18 Billion IDR | 1.97% |
2022 Q3 | 1047.78 Billion IDR | 44.81% |
2022 FY | 3592.83 Billion IDR | -18.28% |
2022 Q4 | 1068.39 Billion IDR | 1.97% |
2022 Q2 | 723.56 Billion IDR | -3.92% |
2022 Q1 | 753.09 Billion IDR | -29.76% |
2021 Q1 | 830.71 Billion IDR | -18.69% |
2021 Q4 | 1072.23 Billion IDR | -26.71% |
2021 FY | 4396.28 Billion IDR | 20.21% |
2021 Q3 | 1463.08 Billion IDR | 42.01% |
2021 Q2 | 1030.25 Billion IDR | 24.02% |
2020 Q1 | 857.27 Billion IDR | -13.06% |
2020 FY | 3657.13 Billion IDR | 4.39% |
2020 Q2 | 932.57 Billion IDR | 8.78% |
2020 Q3 | 845.56 Billion IDR | -9.33% |
2020 Q4 | 1021.7 Billion IDR | 20.83% |
2019 Q4 | 986.04 Billion IDR | 15.06% |
2019 Q1 | 625.18 Billion IDR | -25.33% |
2019 Q2 | 1035.03 Billion IDR | 65.56% |
2019 Q3 | 857.01 Billion IDR | -17.2% |
2019 FY | 3503.28 Billion IDR | 26.01% |
2018 Q4 | 837.3 Billion IDR | 16.05% |
2018 Q2 | 705.03 Billion IDR | 36.54% |
2018 Q1 | 516.35 Billion IDR | -25.09% |
2018 FY | 2780.17 Billion IDR | 26.26% |
2018 Q3 | 721.48 Billion IDR | 2.33% |
2017 Q3 | 575.7 Billion IDR | -1.52% |
2017 Q4 | 689.33 Billion IDR | 19.74% |
2017 Q2 | 584.57 Billion IDR | 65.95% |
2017 Q1 | 352.26 Billion IDR | -41.88% |
2017 FY | 2201.87 Billion IDR | 18.13% |
2016 Q2 | 441.66 Billion IDR | 26.49% |
2016 FY | 1863.89 Billion IDR | 21.29% |
2016 Q4 | 606.14 Billion IDR | 29.82% |
2016 Q1 | 349.17 Billion IDR | -24.63% |
2016 Q3 | 466.9 Billion IDR | 5.71% |
2015 Q3 | 434.64 Billion IDR | 28.98% |
2015 FY | 1536.75 Billion IDR | 10.92% |
2015 Q1 | 301.85 Billion IDR | -32.23% |
2015 Q2 | 336.99 Billion IDR | 11.64% |
2015 Q4 | 463.26 Billion IDR | 6.59% |
2014 Q4 | 445.39 Billion IDR | 15.56% |
2014 FY | 1385.48 Billion IDR | 7.22% |
2014 Q1 | 241.3 Billion IDR | -44.0% |
2014 Q3 | 385.43 Billion IDR | 23.01% |
2014 Q2 | 313.33 Billion IDR | 29.85% |
2013 Q1 | 228.35 Billion IDR | -30.92% |
2013 Q3 | 363.52 Billion IDR | 34.95% |
2013 Q4 | 430.9 Billion IDR | 18.54% |
2013 FY | 1292.15 Billion IDR | 9.95% |
2013 Q2 | 269.36 Billion IDR | 17.96% |
2012 Q3 | 336.9 Billion IDR | 14.75% |
2012 Q4 | 330.55 Billion IDR | -1.89% |
2012 Q1 | 214.1 Billion IDR | -28.53% |
2012 Q2 | 293.6 Billion IDR | 37.13% |
2012 FY | 1175.16 Billion IDR | 13.21% |
2011 Q2 | 222.48 Billion IDR | 16.11% |
2011 Q3 | 324.33 Billion IDR | 45.78% |
2011 Q4 | 299.58 Billion IDR | -7.63% |
2011 FY | 1038.01 Billion IDR | 14.76% |
2011 Q1 | 191.61 Billion IDR | 0.0% |
2010 FY | 904.51 Billion IDR | 14.75% |
2009 FY | 788.25 Billion IDR | 9.14% |
2008 FY | 722.24 Billion IDR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
PT Enseval Putera Megatrading Tbk. | 2913.35 Billion IDR | 4.568% |
PT Itama Ranoraya Tbk | 127.06 Billion IDR | -2088.145% |
PT Millennium Pharmacon International Tbk | 273.37 Billion IDR | -917.016% |
PT Soho Global Health Tbk | 1257.75 Billion IDR | -121.051% |